Apollo Hospitals Dilutes Holding In Arm As Advent International Picks Up Stake
Apollo Hospitals Enterprise Ltd. said on Friday that its shareholding in its subsidiary Apollo HealthCo Ltd. had been diluted as an affiliate of private equity major Advent International has picked up a stake in the company.
The affiliate, Rasmeli Investment, has been allotted 14.85 crore class A and 9.9 crore partly paid-up class B shares of AHL. Consequent to this allotment, the shareholding of Apollo Hospitals in AHL has diluted from 94.9% to approximately 78.8%, according to an exchange filing.
The development comes five months after Apollo Hospitals announced that AHL has secured an investment of Rs 2,475 crore from Rasmeli, as part of the plan to merge the company with the Hyderabad-based Keimed Pvt.
The Proposed Merger
In April, Apollo Hospitals said AHL would be merged with Keimed to form a combined entity and it would be valued at Rs 22,481 crore. The estimated valuation is based on the fact that AHL is currently valued at Rs 14,478 crore and Keimed at Rs 8,003 crore.
Both AHL and Keimed operate in the pharmacy distribution segment where they source and act as wholesale distributors of pharmaceutical, fast-moving consumer goods, and over-the-counter products.
Post the merger, shareholders of Keimed would hold a 25.7% stake and Advent would own 12.1%, whereas Apollo Hospitals would be the majority shareholder.
The amalgamation plan received nod from the Competition Commission of India in August.
Shares of Apollo Hospitals closed 0.92% higher at Rs 7,234 apiece on the NSE, compared to a 0.14% decline in the benchmark Nifty. On a year-to-date basis, the stock has climbed 26.8%.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets